Epidemiology and pathophysiology of cancer-associated thrombosis
dc.contributor.author | Noble, S | en_US |
dc.contributor.author | Pasi, J | en_US |
dc.date.accessioned | 2015-01-05T15:09:30Z | |
dc.date.issued | 2010-04-13 | en_US |
dc.identifier.issn | 0007-0920 | en_US |
dc.identifier.uri | http://qmro.qmul.ac.uk/xmlui/handle/123456789/6319 | |
dc.format.extent | S2 - S9 | en_US |
dc.language.iso | en | en_US |
dc.relation.ispartof | BRIT J CANCER | en_US |
dc.subject | venous thromboembolism | en_US |
dc.subject | thrombosis | en_US |
dc.subject | epidemiology | en_US |
dc.subject | DEEP-VEIN THROMBOSIS | en_US |
dc.subject | VENOUS THROMBOEMBOLISM | en_US |
dc.subject | MULTIPLE-MYELOMA | en_US |
dc.subject | TISSUE FACTOR | en_US |
dc.subject | BREAST-CANCER | en_US |
dc.subject | PULMONARY-EMBOLISM | en_US |
dc.subject | RISK | en_US |
dc.subject | THALIDOMIDE | en_US |
dc.subject | ACTIVATION | en_US |
dc.subject | BEVACIZUMAB | en_US |
dc.title | Epidemiology and pathophysiology of cancer-associated thrombosis | en_US |
dc.type | Article | |
dc.identifier.doi | 10.1038/sj.bjc.6605599 | en_US |
pubs.notes | Not known | en_US |
pubs.volume | 102 | en_US |
Files in this item
This item appears in the following Collection(s)
-
Centre for Immunobiology [1122]